Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Capital Expenditures (2017 - 2025)

Selectis Health's Capital Expenditures history spans 14 years, with the latest figure at $4233.0 for Q3 2025.

  • For Q3 2025, Capital Expenditures rose 766.61% year-over-year to $4233.0; the TTM value through Sep 2025 reached $396824.0, up 1310.13%, while the annual FY2024 figure was $36063.0, 21.0% up from the prior year.
  • Capital Expenditures for Q3 2025 was $4233.0 at Selectis Health, down from $163515.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $239679.0 in Q3 2022 and bottomed at -$108408.0 in Q4 2022.
  • The 5-year median for Capital Expenditures is $34706.5 (2022), against an average of $66377.3.
  • The largest annual shift saw Capital Expenditures plummeted 518.79% in 2022 before it soared 766.61% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $25886.0 in 2021, then tumbled by 518.79% to -$108408.0 in 2022, then surged by 101.77% to $1914.0 in 2023, then soared by 413.9% to $9836.0 in 2024, then plummeted by 56.96% to $4233.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Capital Expenditures are $4233.0 (Q3 2025), $163515.0 (Q2 2025), and $219240.0 (Q1 2025).